Evidence map›Paper›PMID 37274528›Full record

ArticleOpen forum infectious diseases2023

Typhoid Control in an Era of Antimicrobial Resistance: Challenges and Opportunities.

Samantha Vanderslott, Supriya Kumar, Yaw Adu-Sarkodie, Firdausi Qadri, Raphaël M Zellweger

Open access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Combatting extensively drug-resistantPathogens and global health
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 5 countries.

Samantha VanderslottOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom and NIHR Oxford Biomedical Research Centre, Oxford, Oxfordshire, United Kingdom.ORCID https://orcid.org/0000-0001-8685-7758
Supriya KumarEnteric and Diarrheal Diseases, Bill & Melinda Gates Foundation, Seattle, Washington, USA.
Yaw Adu-SarkodieKwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Firdausi QadriInternational Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Raphaël M ZellwegerEpidemiology, Public Health and Impact, International Vaccine Institute, Seoul, South Korea.
Gates Foundation · USInternational Centre for Diarrhoeal Disease Research · BDInternational Vaccine Institute · KRKwame Nkrumah University of Science and Technology · GHUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Historically, typhoid control has been achieved with water and sanitation interventions. Today, in an era of rising antimicrobial resistance (AMR), two World Health Organization-prequalified vaccines are available to accelerate control in the shorter term. Meanwhile, water and sanitation interventions could be implemented in the longer term to sustainably prevent typhoid in low- and middle-income countries. This article first approaches typhoid control from a historical perspective, subsequently presents how vaccination could complement water and sanitation activities, and finally discusses the challenges and opportunities for impactful control of typhoid infection. It also addresses data blind spots and knowledge gaps to focus on for typhoid control and to ultimately progress towards elimination. This article presents a synthesis of discussions held in December 2021 during a roundtable session at the "12th International Conference on Typhoid and Other Invasive Salmonelloses".

Indexed as

salmonellatyphoidtyphoid conjugate vaccinestyphoid control

Identifiers

PMID37274528
PMCPMC10236512
OpenAlexW4379184874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.